PD Dr. med. Christian Weißenberger - Strahlentherapie | Radioonkologie, Freiburg - Publikationen

Zeitschriftenbeiträge (Auswahl)

[1] O. Drognitz, K. Henne, C. Weissenberger, G. Bruggmoser, H. Göbel, U.T. Hopt, H. Frommhold, G. Ruf. Long-term results after intraoperative radiation therapy for gastric cancer. Int. J. Radiat. Oncol. Biol. Phys. 2008; 70(3), 715-21.
[2] M. Henke, D. Mattern, M. Pepe, C. Bézay, C. Weissenberger, M. Werner, F. Pajonk. Do erythropoietin receptors on cancer cells explain unexpected clinical findings? J Clin Oncol. 2006; 24(29): 4708-13.
[3] C. Weissenberger, M. Geissler, F. Otto, A. Barke, K. Henne, G. von Plehn, A. Rein A, C. Muller, S. Bartelt, M. Henke. Anemia and long-term outcome in adjuvant and neoadjuvant radiochemotherapy of stage II and III rectal adenocarcinoma: the Freiburg experience (1989-2002). World J Gastroenterol. 12(12): 1849-58.
[4] C. Weissenberger, D. Müller, J. Beranek-Chiu, M. Neumann, S. Jonassen, S. Bartelt, S. Schulz, G. Witucki, K. Henne, M. Geißler, J. Fogel. Gastrointestinal Cancer Web Sites: How Do They Address Patients’ Concerns? Int J Colorectal Dis. 2006; 21(7): 615-24.
[5] Pajonk F, van Ophoven A, Weissenberger C, McBride WH. The proteasome inhibitor MG-132 sensitizes PC-3 prostate cancer cells to ionizing radiation by a DNA-PK-independent mechanism BMC Cancer 2005, 5:76
[6] Weissenberger C, von Plehn G, Otto F, Geißler M, Barke A, Momm F; Geissler M. Adjuvant radiochemotherapy of stage II and III rectal adenocarcinoma: Role of CEA and CA 19-9. Anticancer Res. 2005; 25: 1787-1794. 2005.
[7] Lutterbach J, Weissenberger C, Hitzer K, Helmes A. [On past practices and future directions of informed consent in (radiation) oncology]. Strahlenther.Onkol. 2004; 180(8): 469 - 477.
[8] Weissenberger C, Jonassen S, Beranek-Chiu J, Neumann M, Muller D, Bartelt S, Schulz S, Monting JS, Henne K, Gitsch G, Witucki G. Breast cancer: patient information needs reflected in English and German web sites. Br.J Cancer 2004; 91(8): 1482-1487.
[9] Bartelt S, Momm F, Weissenberger C, Lutterbach J. Patients with brain metastases from gastrointestinal tract cancer treated with whole brain radiation therapy: Prognostic factors and survival. World J Gastroenterol 2004; 10(22): 3345-3348.
[10] Momm F, Weissenberger C, Bartelt S, Henke M. Moist skin care can diminish acute radiation-induced skin toxicity. Strahlenther Onkol. 2003 Oct;179(10):708-12.

[11] Pajonk F, Weissenberger C, Witucki G, Henke M. Vitiligo at the sites of irradiation in a patient with Hodgkin's disease. Strahlenther.Onkol. 2002; 178[3], 159-162.
[12] Auw-Haedrich C, Boehm C, Weissenberger C. Signet ring carcinoma of the eccrine sweat gland in the eyelid, treated by radiotherapy alone. Br.J Ophthalmol. 2001; 85[1], 112-113.
[13] Weissenberger C, Fiebig HH, Lutterbach J, Barke A, Momm F, Muller M, Witucki G, Guttenberger R, Berger DP. Is there any correlation between MDR1, GST-pi-expression and CEA? Anticancer Res. 2000 Nov-Dec;20(6D):5139-5144.

Buchbeiträge (Auswahl)

1. Weissenberger C: Das Internet als Informationsquelle. Etablierung methodischer Verfahren zur Qualitätsevaluation. 2004; 1 - 17. Gemeinsame Entscheidung in der Krebstherapie : Arzt und Patient im Spannungsfeld der shared decision / Hrsg. H. H. Bartsch ; J. Weis. - Basel ; Freiburg [Breisgau] ; Paris ; London ; New York ; Bangalore ; Bangkok ; Singapore ; Tokyo ; Sydney : Karger, 2004. - XI, 140 S. : graph. Darst. ; 23 cm (Tumortherapie und Rehabilitation)
2. Weissenberger C. Telemedicine in Radiotherapy [Telemedizin in der Strahlentherapie]. In Telemedicine Guide Germany 2002 [Telemedizinführer Deutschland, Ausgabe 2002]. (Ed. A. Jäckel) pp. 230-233, Medizin Forum AG, Ober-Mörlen 2001.
3. Weissenberger C, Fiebig HH, Guttenberger R, Hinkelbein H, Frommhold H. Correlation Between Expression of Drug Resistance, Tumour Markers and Radioresistance. In 3rd Balkan Congress of Oncology. (Ed. G. Antypas) pp. 141-146, 2000.